Estrella Immunopharma Cash Flow Statement (2021-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-0.11M	-0.14M	-0.14M	-0.36M	-0.34M	-5.72M	-8.40M	-0.14M	-1.87M	-1.02M	-0.47M	-4.42M	-7.80M	-4.43M	-2.10M	-5.54M	-4.80M	2.13M	-2.29M	-2.31M
Share-based Compensation (Quarter)		0.20M			0.10M	0.20M	0.31M		1.19M					0.43M	0.16M	0.16M	0.15M	0.15M	0.15M	0.15M
Deferred Taxes (Quarter)							-0.02M	-0.02M
Gains from Investment Securities (Quarter)																				0.22M
Cash from Operations (Quarter)																				-1.80M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)						0.01M	0.01M
Change in Working Capital
Change in Account Payables (Quarter)																				-0.01M
Change in Accured Expenses (Quarter)																				4.14M
Change in Taxes (Quarter)					800.00	0.00M	0.04M	0.01M	-612.00	674.00				-0.04M
Other Working Capital Changes (Quarter)																				-0.05M
Investing Activities
Cash from Investing Activities (Quarter)	-42.00M						-0.14M	0.10M	-0.11M	5.07M
Financing Activities
Other financing activities (Quarter)																				4.00
Cash from Financing Activities (Quarter)																				4.00
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)																	1.05M		8.00M
Additional items
Change in Cash (Quarter)																				-1.78M
Free Cash Flow (Quarter)																				-1.80M
Net Cash Flow (Quarter)																				-1.80M

Estrella Immunopharma ESLA Cash Flow Statement (2021-2026)